Buscar
Mostrando ítems 1-10 de 22
A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults
(Blackwell Publishing LtdOxfordInglaterra, 2004)
Efeitos do uso crônico do amprenavir sobre a prenhez da rata albina
(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2004-04-01)
OBJECTIVE: to evaluate the chronic effects of amprenavir on implantations, reabsorptions, fetuses, placentae, and maternal and fetal mortality in the albino rat. METHODS: five groups of EPM-1 Wistar pregnant rats were used: ...
Acao cronica do amprenavir sobre a prenhez da rata albina(Rattus norvegicus albinus, Rodentia, Mammalia)
(Universidade Federal de São Paulo (UNIFESP), 2003)
Objetivo: avaliar a acao cronica do amprenavir sobre a prenhez da rata albina. Metodo: utilizaram-se 50 ratas albinas da linhagem EPM-1 Wistar, pesando, em media 230g, divididas em cinco grupos numericamente iguais, sendo ...
Nelfinavir-Resistant, Amprenavir-Hypersusceptible Strains of Human Immunodeficiency Virus Type 1 Carrying an N88S Mutation in Protease Have Reduced Infectivity, Reduced Replication Capacity, and Reduced Fitness and Process the Gag Polyprotein Precursor Aberrantly
(American Society for Microbiology, 2002-09)
The evolution of human immunodeficiency virus type 1 (HIV-1) strains with reduced susceptibility to protease inhibitors (PIs) is a major cause of PI treatment failure. A subset of subjects failing a therapy regimen containing ...
Consenso em criptococose - 2008
(2008-09-01)
Consenso em criptococose - 2008
(2008-09-01)
Effectiveness of commercial inhibitors against subtype F HIV-1 protease
(TAYLOR & FRANCIS LTD, 2009)
Subtype F wild type HIV protease has been kinetically characterized using six commercial inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir) commonly used for HIV/AIDS treatment, as well as ...
Triterpenos como Inibidores de Fusão: Uma Nova Estratégia no Combate ao Vírus HIVTriterpenes as Fusion Inhibitors: A New Strategy Against HIV Virus
(Fundação Oswaldo Cruz. Farmanguinhos. Núcleo de Gestão em Biodiversidade e Saúde., 2017)
Antiretroviral resistance and genetic diversity of human immunodeficiency virus type 1 isolates from the Federal District, Central Brazil
(Instituto Oswaldo Cruz, Ministério da Saúde, 2004)
In the context of universal access to antiretroviral therapy, the surveillance of human immunodeficiency virus type 1 (HIV-1) genetic diversity and resistance becomes pivotal. In this work our purpose was to describe the ...